JPRN-UMIN000042849已完成未知
A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of Anti-Stress Efficacy of Complementary-Alternative Medicine in Healthy subjects - A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of Anti-Stress Efficacy of Complementary-Alternative Medicine in Healthy subjects
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Subjects who have a history of cardiac diseases like arrhythmia. 2)Subjects who have a history of allergic symptoms by the ginseng. 3)Subjects who have a history of allergic symptoms by food. 4)Subjects who have a history of mental disease. 5)Subjects who have a history of using antipsychotic drug. 6)Subjects who use a drug to treat a disease. 7)Subjects who ingest supplements or energy drinks include ginseng. 8)Subjects who can't stop use of health food such as supplements, energy drinks. 9)Subjects who are a color-blind person. 10)Subjects who are a smoker. 11)Subjects who have abnormal score of amylase and cortisol in saliva, blood pressure and heart rate. 12)Subjects who suffered pain usually. 13)Subjects who participated in other clinical studies. 14)Subjects who take foods or dinks which are not provided from noon to fifteen on the day of study.
研究者
相似试验
进行中（未招募）
1 期
This is a multinational study comparing the efficacy and safety of two medicines , solifenacin succinate and mirabegron taken together, or separately, or a mock treatment (placebo) in subjects with symptoms of overactive bladder.MedDRA version: 17.1Level: LLTClassification code 10059617Term: Overactive bladderSystem Organ Class: 100000004857Overactive BladderEUCTR2012-005735-91-DEAstellas Pharma Europe B.V.7,000
进行中（未招募）
不适用
A study to investigate the effect of the drug Lu AA21004 on the intellectual function in people who suffer from depressioCognitive Function in Major Depressive Disorder (MDD)EUCTR2011-005298-22-FITakeda Global Research & Development Centre (Europe) Ltd600
进行中（未招募）
1 期
A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of SM-13496 for the Treatment of Bipolar I DepressioBipolar I depressionMedDRA version: 18.0Level: LLTClassification code 10004936Term: Bipolar depressionSystem Organ Class: 100000004873EUCTR2013-003038-34-SKSumitomo Dainippon Pharma Co., Ltd.525
进行中（未招募）
1 期
Study of the Efficacy and Safety of Olokizumab in Patients with Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate TherapyEUCTR2015-005307-83-LTR-Pharm1,575
进行中（未招募）
1 期
Study of the Efficacy and Safety of Olokizumab in Patients with Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate TherapyEUCTR2015-005307-83-DER-Pharm1,575